Q1/2024: Monthly: Fate Therapeutics (FATE: $7.34) in top 4% performers of NASDAQ market in past quarter

Press/Media

Period1 Apr 2024

Media coverage

1

Media coverage

  • TitleQ1/2024: Monthly: Fate Therapeutics (FATE: $7.34) in top 4% performers of NASDAQ market in past quarter
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date1/04/24
    PersonsJared Scott
View all 1
View less